• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法布里病患者外周血管的结构和功能变化。

Structural and functional changes in peripheral vasculature of Fabry patients.

作者信息

Kalliokoski Riikka J, Kalliokoski Kari K, Penttinen Maila, Kantola Ilkka, Leino Aila, Viikari Jorma S, Simell Olli, Nuutila Pirjo, Raitakari Olli T

机构信息

Turku PET Centre, University of Turku, Turku, Finland.

出版信息

J Inherit Metab Dis. 2006 Oct;29(5):660-6. doi: 10.1007/s10545-006-0340-x. Epub 2006 Aug 12.

DOI:10.1007/s10545-006-0340-x
PMID:16906474
Abstract

OBJECTIVE

Fabry disease is a lysosomal storage disorder due to deficient alpha-galactosidase A activity, which leads to glycosphingolipid accumulation especially in vascular smooth-muscle and endothelial cells. Little is known about the effects of Fabry disease on peripheral artery function and structure. Therefore, we aimed to further characterize the peripheral vascular structural and functional changes in Fabry disease.

METHODS AND RESULTS

We measured structural and functional vascular parameters, including intima-media thickness (IMT) of brachial and carotid arteries and abdominal aorta, carotid and aortic compliance, and brachial artery flow-mediated dilatation (FMD) in 17 Fabry patients and 34 healthy controls matched for age, sex and smoking. Carotid IMT (0.64 +/- 0.15 vs 0.57 +/- 0.12 mm), brachial IMT (1.02 +/- 0.25 vs 0.74 +/- 0.18 mm), and aortic IMT (0.31 +/- 0.09 vs 0.26 +/- 0.04 mm) were significantly increased, and brachial FMD was significantly impaired (6.3 +/- 5.0 vs 9.7 +/- 3.9%) in Fabry patients compared to healthy controls (p < 0.05 in all comparisons after adjustments for age, LDL-cholesterol, and systolic blood pressure). No differences were observed in arterial compliance between the groups.

CONCLUSIONS

These data suggest that Fabry disease affects arterial function and structure by disturbing peripheral endothelial function and promoting intima-media thickening.

摘要

目的

法布里病是一种溶酶体贮积症,因α-半乳糖苷酶A活性缺乏所致,可导致糖鞘脂蓄积,尤其是在血管平滑肌和内皮细胞中。关于法布里病对外周动脉功能和结构的影响,目前知之甚少。因此,我们旨在进一步明确法布里病患者外周血管结构和功能的变化。

方法与结果

我们测量了17例法布里病患者和34例年龄、性别及吸烟情况相匹配的健康对照者的血管结构和功能参数,包括肱动脉、颈动脉及腹主动脉的内膜中层厚度(IMT)、颈动脉和主动脉顺应性以及肱动脉血流介导的舒张功能(FMD)。与健康对照者相比,法布里病患者的颈动脉IMT(0.64±0.15对0.57±0.12mm)、肱动脉IMT(1.02±0.25对0.74±0.18mm)和主动脉IMT(0.31±0.09对0.26±0.04mm)显著增加,肱动脉FMD显著受损(6.3±5.0对9.7±3.9%)(在对年龄、低密度脂蛋白胆固醇和收缩压进行校正后的所有比较中,p<0.05)。两组间动脉顺应性未观察到差异。

结论

这些数据表明,法布里病通过扰乱外周内皮功能和促进内膜中层增厚来影响动脉功能和结构。

相似文献

1
Structural and functional changes in peripheral vasculature of Fabry patients.法布里病患者外周血管的结构和功能变化。
J Inherit Metab Dis. 2006 Oct;29(5):660-6. doi: 10.1007/s10545-006-0340-x. Epub 2006 Aug 12.
2
Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease.
J Inherit Metab Dis. 2005;28(4):563-73. doi: 10.1007/s10545-005-0563-2.
3
Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction.吸烟与内膜中层厚度增加及内皮功能障碍呈剂量相关。
Angiology. 1999 Mar;50(3):201-8. doi: 10.1177/000331979905000304.
4
Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease.在患有法布里病的成年人群中,无动脉粥样硬化斑块时颈动脉内膜中层厚度增加。
Acta Paediatr Suppl. 2006 Apr;95(451):63-8. doi: 10.1111/j.1651-2227.2006.tb02392.x.
5
Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.通过内皮功能障碍和内膜中层厚度早期检测2型糖尿病患者的动脉粥样硬化。
Rom J Intern Med. 2004;42(2):343-54.
6
Endothelial dysfunction predictor of structural changes of arterial wall in type I diabetes.1型糖尿病患者动脉壁结构改变的内皮功能障碍预测指标
Int Angiol. 2006 Sep;25(3):280-6.
7
[Ultrasonographic evaluation of atherosclerotic changes in carotid and brachial arteries in children with growth hormone deficiency before GH replacement therapy].[生长激素替代治疗前生长激素缺乏儿童颈动脉和肱动脉粥样硬化改变的超声评估]
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2005;11(2):85-90.
8
Arterial remodelling in Fabry disease.
Acta Paediatr Suppl. 2002;91(439):62-6. doi: 10.1111/j.1651-2227.2002.tb03113.x.
9
Cardiac and vascular hypertrophy in Fabry disease: evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition.法布里病中心脏和血管肥大:一种独立于血压和糖鞘脂沉积的新机制的证据。
Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):839-44. doi: 10.1161/01.ATV.0000209649.60409.38. Epub 2006 Feb 9.
10
[Ultrasonographic evaluation of atherosclerotic changes in carotid and brachial arteries in obese and hypertensive children].[肥胖和高血压儿童颈动脉和肱动脉粥样硬化改变的超声评估]
Przegl Lek. 2005;62(12):1346-51.

引用本文的文献

1
Relationship between Capillaroscopic Architectural Patterns and Different Variant Subgroups in Fabry Disease: Analysis of Cases from a Multidisciplinary Center.毛细血管袢形态与法布雷病不同变异亚群的关系:多学科中心病例分析。
Genes (Basel). 2024 Aug 21;15(8):1101. doi: 10.3390/genes15081101.
2
Inflammation, Oxidative Stress, and Endothelial Dysfunction in the Pathogenesis of Vascular Damage: Unraveling Novel Cardiovascular Risk Factors in Fabry Disease.在血管损伤发病机制中的炎症、氧化应激和内皮功能障碍:法布里病中新型心血管风险因素的研究。
Int J Mol Sci. 2024 Jul 29;25(15):8273. doi: 10.3390/ijms25158273.
3
Cardiopulmonary determinants of reduced exercise tolerance in Fabry disease.

本文引用的文献

1
Small-fibre neuropathy in female Fabry patients: reduced allodynia and skin blood flow after topical capsaicin.女性法布里病患者的小纤维神经病变:外用辣椒素后痛觉过敏和皮肤血流减少
J Peripher Nerv Syst. 2006 Jun;11(2):119-25. doi: 10.1111/j.1085-9489.2006.00076.x.
2
Schiffmann R, Rapkiewicz A, Abu-Asab M, Ries M, Askari H, Tsokos M, Quezado M. Pathological findings in a patient with Fabry disease, who died after 2.5 years of enzyme replacement. Virchows Arch. 2005 Nov 29; 1-7.
Virchows Arch. 2006 Jun;448(6):873. doi: 10.1007/s00428-006-0170-0. Epub 2006 Mar 8.
3
Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study.儿童期确定的危险因素与成年期颈动脉弹性降低:芬兰年轻人心血管风险研究
法布里病运动耐量降低的心肺决定因素。
Front Cardiovasc Med. 2024 May 2;11:1396996. doi: 10.3389/fcvm.2024.1396996. eCollection 2024.
4
Overexpression of VEGFα as a biomarker of endothelial dysfunction in aortic tissue of α-GAL-Tg/KO mice and its upregulation in the serum of patients with Fabry's disease.血管内皮生长因子α(VEGFα)在α-半乳糖苷酶转基因/敲除(α-GAL-Tg/KO)小鼠主动脉组织中作为内皮功能障碍生物标志物的过表达及其在法布里病患者血清中的上调。
Front Cardiovasc Med. 2024 Feb 5;11:1355033. doi: 10.3389/fcvm.2024.1355033. eCollection 2024.
5
Fatigue as hallmark of Fabry disease: role of bioenergetic alterations.疲劳作为法布里病的标志:生物能量改变的作用。
Front Cardiovasc Med. 2024 Jan 24;11:1341590. doi: 10.3389/fcvm.2024.1341590. eCollection 2024.
6
Fabry disease: Mechanism and therapeutics strategies.法布里病:发病机制与治疗策略
Front Pharmacol. 2022 Oct 26;13:1025740. doi: 10.3389/fphar.2022.1025740. eCollection 2022.
7
Anderson-Fabry Disease: From Endothelial Dysfunction to Emerging Therapies.安德森-法布里病:从内皮功能障碍到新兴疗法
Adv Pharmacol Pharm Sci. 2021 May 13;2021:5548445. doi: 10.1155/2021/5548445. eCollection 2021.
8
Biomarkers in Fabry Disease. Implications for Clinical Diagnosis and Follow-up.法布里病的生物标志物。对临床诊断和随访的意义。
J Clin Med. 2021 Apr 13;10(8):1664. doi: 10.3390/jcm10081664.
9
Exploiting the Potential of Models in Lysosomal Storage Disorders: Pathological Mechanisms and Drug Discovery.挖掘溶酶体贮积症模型的潜力:病理机制与药物发现
Biomedicines. 2021 Mar 7;9(3):268. doi: 10.3390/biomedicines9030268.
10
Evaluation of Cerebral Microvascular Regulatory Mechanisms with Transcranial Doppler in Fabry Disease.法布里病中经颅多普勒对脑微血管调节机制的评估
Brain Sci. 2020 Aug 7;10(8):528. doi: 10.3390/brainsci10080528.
Circulation. 2005 Sep 6;112(10):1486-93. doi: 10.1161/CIRCULATIONAHA.104.502161. Epub 2005 Aug 29.
4
Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A.男性安德森-法布里病患者的冠状动脉微血管功能障碍及α-半乳糖苷酶A治疗的效果
Heart. 2006 Mar;92(3):357-60. doi: 10.1136/hrt.2004.054015. Epub 2005 Aug 5.
5
Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease.
J Inherit Metab Dis. 2005;28(4):563-73. doi: 10.1007/s10545-005-0563-2.
6
Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency.α-半乳糖苷酶A缺乏会加速载脂蛋白E缺乏小鼠的动脉粥样硬化进程。
Circulation. 2005 Feb 8;111(5):629-32. doi: 10.1161/01.CIR.0000154550.15963.80. Epub 2005 Jan 24.
7
Geographic origin as a determinant of carotid artery intima-media thickness and brachial artery flow-mediated dilation: the Cardiovascular Risk in Young Finns study.地理起源作为颈动脉内膜中层厚度和肱动脉血流介导的扩张的决定因素:年轻芬兰人心血管风险研究
Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):392-8. doi: 10.1161/01.ATV.0000150042.43866.7f. Epub 2004 Nov 11.
8
Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes.1型糖尿病患儿的内皮功能障碍与动脉内膜中层厚度增加
Circulation. 2004 Apr 13;109(14):1750-5. doi: 10.1161/01.CIR.0000124725.46165.2C. Epub 2004 Mar 15.
9
Sequelae of storage in Fabry disease--pathology and comparison with other lysosomal storage diseases.法布里病中的储存后遗症——病理学及与其他溶酶体储存疾病的比较
Acta Paediatr Suppl. 2003 Dec;92(443):46-53; discussion 45. doi: 10.1111/j.1651-2227.2003.tb00222.x.
10
Postischemic cutaneous hyperperfusion in the presence of forearm hypoperfusion suggests sympathetic vasomotor dysfunction in Fabry disease.在前臂灌注不足的情况下出现缺血后皮肤过度灌注提示法布里病存在交感神经血管舒缩功能障碍。
J Neurol. 2003 Aug;250(8):970-6. doi: 10.1007/s00415-003-1133-x.